CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

CDMO Subsection

Insights into the latest developments in CDMO services and manufacturing.

Continue reading

Injectables Subsection

Expert perspectives on the evolving needs of injectable therapies and packaging.

Continue reading

Nasal & Pulmonary Subsection

Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability

Continue reading

Advertisement

CPHI Milan
DDL 2026

Advertisement

Merxin March 2026

Advertisement

Lifecore Biomedical

Advertisement

Solstice

Advertisement

Nipro April 2026

Wickham Laboratories Holdings Announces Planning Application Approval

Outline planning permission application for expansion of the Hoeford Point site now approved.

Wickham Laboratories Ltd Hoeford Point Site

Wickham Laboratories Holdings, owner of Wickham Laboratories Ltd, today announces approval of its application for planning permission to construct additional buildings on the Hoeford Point site.

These buildings are to be situated adjacent to the current Wickham Laboratories facilities and represent an overall expansion of the group’s business ventures.
This planning application is for 5 separate buildings, constructed over a period of time as yet to be agreed, with an intended use in the area of science and technology.
Wickham Laboratories Holdings is pleased that the application has been approved and planning can now progress for additional facilities to attract further development and jobs to the local area.
Company Overview
As a GMP/GLP compliant laboratory with over 50 years of experience, Wickham Laboratories Ltd is an established name in the fields of pharmaceutical and medical device contract testing, research and consultancy. We conduct business with clients worldwide and the combined expertise of our laboratory technicians and managers enables us to be fully conversant with global regulatory expectations. We are committed to providing a quality testing service, combining high levels of client satisfaction together with the maintenance of appropriate accreditation. This and the continual pursuit of delivering excellence remain central to our business. We are routinely inspected by the MHRA, FDA and Home Office and welcome enquiries from interested parties.
For more information about Wickham Laboratories Limited and our services, please contact us at +44 (0)1329 226600 or mail@wickhamlabs.co.uk. To directly request a company brochure, please visit the Resource Centre section of our company website.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Tjoapack
Aptar – 08/01/2026